Top Maryland Biotech Startups (44)
.png)
PF is a consulting firm providing biomanufacturing strategy and execution. Our services include turnkey capital projects and facility builds; owner's representation and program/project management; validation; quality, regulatory and compliance; engineering and automation and more. We partner with startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, financial institutions, and CROs/CMOs. One of our core values is giving back. Volunteering at...
Sisu is a medical device company that designs and commercializes medical devices with and for emerging markets.
Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases.
Quality Biological (QBI) provides quality solutions for life science research and bioproduction applications. We specialize in producing custom and standard cell culture and molecular biology reagents, buffers, and liquid solutions and providing supporting services. At QBI, we help our clients achieve their application goals faster. We do this by being flexible and nimble, providing a level of personalized service our...
Brinkbit is a fast, extensible, and scalable BaaS platform for game services, content management, live ops, and more!
RS BioTherapeutic’s first investigational compound (RSBT-001) is a semi-synthetic, nebulized, cannabidiolic acid complex in development to address exacerbation and prevent progression of both acute and chronic pulmonary inflammation related to respiratory diseases including COPD, SARS-COV-2, Cystic Fibrosis, Asthma, Bronchitis, and Acute Respiratory Distress Syndrome. Our premise is that RSBT1 provides therapeutic benefit through modulation of the Interleukin response to inflammation...
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization. Over the past 20 years, we have developed and commercialized our proprietary Flow Electroporation® platform, which facilitates complex engineering of a wide variety of cells. Our ExPERT™ platform, which is based on...
Intralytix is a biotechnology company focused on the discovery, production and marketing.
Elixirgen Scientific, launched in 2016, is a Baltimore-based biotechnology company focused on stem cell related technology.
NuPulse is a medical device company developing novel technology to treat patients with heart failure.
Medcura, Inc. has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. The company has achieved milestones such as 3 FDA Clearances, 6 issued patents, and 7 peer-reviewed publications.
Fzata, Inc. is a pre-clinical stage biopharmaceutical company based in Halethorpe, MD within the vibrant BioHealth Capital Region. Fzata’s vision is to reduce health inequities by expanding patient access to therapeutic biologics. This is made possible with our proprietary first-in-class oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. BioPYM enables orally administered yeast micro-factories to make biologic therapeutics “on-site” in the...
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world.
Glyscend develops a revolutionary approach to treating type 2 diabetes.
Texcell-North America, Inc. is a global contract research organization based in the Maryland/Virginia biotech corridor specializing in custom cell culture, virus propagation, virus concentration, viral clearance services, and viral safety testing in support of biopharmaceutical applications submitted to the FDA and other regulatory authorities. Since 2002, our team has cultivated an ever-increasing range of experience performing viral clearance studies for...
OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive,...
VakSea is a biotechnology company that makes immune-boosting protein to immunize and protect shrimp from the disease.
NexImmune is a publicly traded, clinical stage biotechnology company developing unique approaches to T cell immunotherapies based on its propriety Artificial Immune Modulation (AIM™) technology. NexImmune has a differentiated platform and pipeline of product candidates in pre-clinical and phase 1/2 stages with lead programs focused on the treatment of relapsed acute myeloid leukemia (AML) after allogenic stem cell transplantation and...
